(1â3)-ß-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.

White, Sandra K; Schmidt, Robert L; Walker, Brandon S; Hanson, Kimberly E

(1â3)-ß-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.

White, Sandra K; Schmidt, Robert L; Walker, Brandon S; Hanson, Kimberly E.

Afiliação

White SK; Department of Pathology, University of Utah, School of Medicine, Salt Lake City, Utah, USA.
Schmidt RL; Department of Pathology, University of Utah, School of Medicine, Salt Lake City, Utah, USA.
Walker BS; ARUP Laboratories, Salt Lake City, Utah, USA.
Hanson KE; Director, Transplant Infectious Diseases and Immunocompromised Host Service, Section Head, Clinical Microbiology, Director, Medical Microbiology Fellowship Program, University of Utah and ARUP Laboratories, Salt Lake City, Utah, USA.

Cochrane Database Syst Rev ; 7: CD009833, 2020 07 21.

Article em En | MEDLINE | ID: mdl-32693433

Assuntos

Estado Terminal; Hospedeiro Imunocomprometido; Infecções Fúngicas Invasivas/diagnóstico; beta-Glucanas/sangue; Aspergilose/diagnóstico; Biomarcadores/sangue; Candidíase Invasiva/diagnóstico; Estudos de Casos e Controles; Humanos; Infecções por Pneumocystis/diagnóstico; Pneumocystis carinii; Estudos Prospectivos; Curva ROC; Estudos Retrospectivos; Sensibilidade e Especificidade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hospedeiro Imunocomprometido / Estado Terminal / Beta-Glucanas / Infecções Fúngicas Invasivas Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google